Augmentation Treatments with Second-generation Antipsychotics to Antidepressants in Treatment-resistant Depression
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Augmentation Treatments with Second-generation Antipsychotics to Antidepressants in Treatment-resistant Depression
Authors
Keywords
Major Depressive Disorder, Risperidone, Olanzapine, Quetiapine, Aripiprazole
Journal
CNS DRUGS
Volume 27, Issue S1, Pages 11-19
Publisher
Springer Nature
Online
2013-05-24
DOI
10.1007/s40263-012-0029-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Aripiprazole Augmentation in Major Depressive Disorder: A Double-Blind, Placebo-Controlled Study in Patients with Inadequate Response to Antidepressants
- (2016) Robert M. Berman et al. CNS SPECTRUMS
- The Effectiveness and Safety of Adjunctive Aripiprazole in Taiwanese Patients With Antidepressant-Refractory Major Depressive Disorder
- (2011) Shaw-Ji Chen et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Lifetime risk and age of onset distributions of psychiatric disorders: analysis of national sample survey in South Korea
- (2011) Maeng Je Cho et al. SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY
- Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder
- (2011) Robert Berman et al. Neuropsychiatric Disease and Treatment
- Efficacy and safety of adjunctive aripiprazole in major depressive disorder in older patients: a pooled subpopulation analysis
- (2010) David C. Steffens et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study
- (2010) Nizar El-Khalili et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- A pooled analysis of two randomised, placebo-controlled studies of extended release quetiapine fumarate adjunctive to antidepressant therapy in patients with major depressive disorder
- (2010) Michael Bauer et al. JOURNAL OF AFFECTIVE DISORDERS
- Atypical Antipsychotic Augmentation in Major Depressive Disorder: A Meta-Analysis of Placebo-Controlled Randomized Trials
- (2009) J. Craig Nelson et al. AMERICAN JOURNAL OF PSYCHIATRY
- Efficacy of Risperidone Augmentation to Antidepressants in the Management of Suicidality in Major Depressive Disorder
- (2009) Hollis Reeves et al. JOURNAL OF CLINICAL PSYCHIATRY
- Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder
- (2009) Michael Bauer et al. JOURNAL OF CLINICAL PSYCHIATRY
- An Integrated Analysis of Olanzapine/Fluoxetine Combination in Clinical Trials of Treatment-Resistant Depression
- (2009) Madhukar H. Trivedi et al. JOURNAL OF CLINICAL PSYCHIATRY
- The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder
- (2009) Ronald N. Marcus et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Metabolic Assessment of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder
- (2009) Maurizio Fava et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- A randomized, placebo-controlled trial of risperidone augmentation for patients with difficult-to-treat unipolar, non-psychotic major depression
- (2008) Gabor I. Keitner et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Placebo-Controlled Study of Relapse Prevention With Risperidone Augmentation in Older Patients with Resistant Depression
- (2007) George S. Alexopoulos et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now